KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Accumulated Expenses (2016 - 2025)

Stereotaxis (STXS) has disclosed Accumulated Expenses for 16 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 41.68% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 41.68% decrease, with the full-year FY2024 number at $2.9 million, down 1.68% from a year prior.
  • Accumulated Expenses was $2.0 million for Q3 2025 at Stereotaxis, up from $1.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.4 million in Q3 2024 to a low of $1.7 million in Q2 2025.
  • A 5-year average of $2.7 million and a median of $2.9 million in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 42.55% in 2023, then plummeted 41.68% in 2025.
  • Stereotaxis' Accumulated Expenses stood at $2.5 million in 2021, then surged by 30.78% to $3.3 million in 2022, then decreased by 10.1% to $3.0 million in 2023, then dropped by 1.68% to $2.9 million in 2024, then crashed by 32.61% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Accumulated Expenses are $2.0 million (Q3 2025), $1.7 million (Q2 2025), and $2.9 million (Q1 2025).